Hosie Patrick, Fitzgerald Dominic A, Jaffe Adam, Birman Catherine S, Morgan Lucy
Discipline of Paediatrics, School of Women's and Children's Health, University of New South Wales, New South Wales, Australia; Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney Medical School, Sydney, New South Wales, Australia.
J Paediatr Child Health. 2014 Dec;50(12):952-8. doi: 10.1111/jpc.12628. Epub 2014 Jun 18.
Primary ciliary dyskinesia (PCD) is a multi-organ disorder associated with chronic oto-sino-pulmonary disease, neonatal respiratory distress, situs abnormalities and reduced fertility. Repeated respiratory tract infections leads to the almost universal development of bronchiectasis. These clinical manifestations are a consequence of poorly functioning motile cilia. However, confirming the diagnosis is quite difficult and is often delayed, so the true incidence of PCD may be significantly higher than current estimates. Nasal nitric oxide has been earmarked as a useful screening tool for identifying patients, but its use is limited in pre-school-aged children. Due to the rarity of PCD, the evidence base for management is somewhat limited, and treatment regimens are extrapolated from other suppurative lung disorders, like cystic fibrosis.
原发性纤毛运动障碍(PCD)是一种多器官疾病,与慢性耳-鼻-肺疾病、新生儿呼吸窘迫、内脏反位异常和生育能力下降有关。反复的呼吸道感染几乎普遍导致支气管扩张。这些临床表现是运动性纤毛功能不良的结果。然而,确诊相当困难且常常延迟,因此PCD的实际发病率可能显著高于目前的估计。鼻一氧化氮已被指定为识别患者的有用筛查工具,但其在学龄前儿童中的应用有限。由于PCD罕见,管理的证据基础有些有限,治疗方案是从其他化脓性肺部疾病(如囊性纤维化)推断而来的。